Permira-backed Neuraxpharm, an European specialty pharmaceutical company, completed its acquisition of Medinutrix, an Irish pharma company.Financial terms were not disclosed. “When we founded Medinutrix, we dedicated ourselves to be a specialty pharmaceutical company delivering real value to patients and healthcare professionals. We are enthusiastic about our future as Neuraxpharm Ireland and the opportunity to work with such a dynamic and experienced team, to bring further innovative medicines to patients in Ireland,” Dave Shanahan, Medinutrix Founder.